Executive Branch

A new poll has the Arizona marijuana legalization initiative at 51%, the natural psychedelic decriminalization movement comes to Ann Arbor, and more.

There is a landmark settlement in the killing of Breonna Taylor, the federal government hints at a move toward the use of hair follicle testing for federal employees, and more.

Joe Biden's approach to drug policy appears still rooted in the last century, the Trump administration releases mandatory guidelines for hair follicle testing for truck drivers, and more.

Vermont legislators look to reconcile House and Senate legal marijuana sales bills, UN officials in Colombia denounce an increasing number of massacres, and more.

After the first decline in drug ODs in decades in 2018, the number jumped again last year, the CDC says; Canadian psychotherapists want the ability to use psilocybin themselves to better treat patients using the drug, and more.

Things haven't gone exactly as planned.

From marijuana to psychedelics to the lingering overdose crisis to the emergence of a new vaping-related illness, a lot happened in 2019. Here are ten of the biggest highs and lows.

Bill Barr is accused of improperly pushing probes of legal marijuana companies, DARPA is funding research into psychedelic-inspired drugs for military purposes, Virginia's Black Legislative Caucus wants marijuana legalized this summer, and more.

Georgia Senate Democrats have filed a police reform bill that includes marijuana decriminalization, the US is ramping up anti-drug operations near Venezuela, Israel takes a step toward marijuana legalization, and more.

Police accountability is the topic of the day in Congress and in Colorado, a Nebraska medical marijuana initiative campaign is in a final sprint for signatures, and more.